210 related articles for article (PubMed ID: 26907932)
1. Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.
Gupta K; McCannel CA; Kamrava M; Lamb J; Almanzor RD; McCannel TA
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1371-8. PubMed ID: 26907932
[TBL] [Abstract][Full Text] [Related]
2. Association between Tumor Regression Rate and Gene Expression Profile after Iodine 125 Plaque Radiotherapy for Uveal Melanoma.
Mruthyunjaya P; Seider MI; Stinnett S; Schefler A;
Ophthalmology; 2017 Oct; 124(10):1532-1539. PubMed ID: 28549517
[TBL] [Abstract][Full Text] [Related]
3. Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.
Klufas MA; Itty S; McCannel CA; Glasgow BJ; Moreno C; McCannel TA
JAMA Ophthalmol; 2015 Sep; 133(9):1073-6. PubMed ID: 26086628
[TBL] [Abstract][Full Text] [Related]
4. Vitrectomy and Vitrector Port Needle Biopsy of Choroidal Melanoma for Gene Expression Profile Testing Immediately before Brachytherapy.
Reddy DM; Mason LB; Mason JO; Crosson JN; Yunker JJ
Ophthalmology; 2017 Sep; 124(9):1377-1382. PubMed ID: 28461017
[TBL] [Abstract][Full Text] [Related]
5. Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma.
McCannel TA; Chang MY; Burgess BL
Ophthalmology; 2012 Mar; 119(3):606-10. PubMed ID: 22226884
[TBL] [Abstract][Full Text] [Related]
6. Relationship between rate of posterior uveal melanoma flattening following plaque radiotherapy and gene expression profile class of tumor cells.
Corrêa ZM; Augsburger JJ
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):556-9. PubMed ID: 24408979
[TBL] [Abstract][Full Text] [Related]
7. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
[TBL] [Abstract][Full Text] [Related]
9. Regression patterns of choroidal melanoma: After palladium-103 (
Maheshwari A; Finger PT
Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
[TBL] [Abstract][Full Text] [Related]
10. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
11. Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy.
Marathe OS; Wu J; Lee SP; Yu F; Burgess BL; Leu M; Straatsma BR; McCannel TA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1046-8. PubMed ID: 20932685
[TBL] [Abstract][Full Text] [Related]
12. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
[TBL] [Abstract][Full Text] [Related]
13. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2020 Apr; 127(4S):S148-S157. PubMed ID: 32200815
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma.
Chang MY; Rao NP; Burgess BL; Johnson L; McCannel TA
Mol Vis; 2013; 19():1892-900. PubMed ID: 24049435
[TBL] [Abstract][Full Text] [Related]
15. Visual acuity, oncologic, and toxicity outcomes with
Patel KR; Prabhu RS; Switchenko JM; Chowdhary M; Craven C; Mendoza P; Danish H; Grossniklaus HE; Aaberg TM; Aaberg T; Reddy S; Butker E; Bergstrom C; Crocker IR
Brachytherapy; 2017; 16(3):646-653. PubMed ID: 28262517
[TBL] [Abstract][Full Text] [Related]
16. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
[TBL] [Abstract][Full Text] [Related]
17. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
18. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative sonographically assisted radioactive iodine 125 plaque brachytherapy for choroidal melanoma: visual acuity outcome.
Quinlan-Davidson S; AlMahmoud T; Shenouda G; Evans M; Mansour M; Edelstein C; Pond G; Deschênes J
J Ultrasound Med; 2013 Jun; 32(6):995-1001. PubMed ID: 23716521
[TBL] [Abstract][Full Text] [Related]
20. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
